No Downstaging After Short-Term Preoperative Radiotherapy in Rectal Cancer Patients
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
PURPOSE: In retrospective studies, total mesorectal excision (TME) surgery has been demonstrated to result in a reduction in the number of local recurrences of rectal cancer. Reports on improved local control after preoperative, hypofractionated radiotherapy have led to the introduction of a randomized multicenter trial to evaluate the effect of TME surgery with and without preoperative radiotherapy. Treatment with preoperative radiotherapy might have an effect on the pathologic characteristics that determine staging of rectal cancer. We investigated the occurrence of downstaging in rectal cancer patients treated with and without preoperative radiotherapy. PATIENTS AND METHODS: We analyzed the differences in tumor size, number of examined lymph nodes, tumor-node-metastasis stage, and histopathologic features in 1,321 patients entered onto a randomized trial. The trial compared preoperative radiotherapy (5 × 5 Gy) followed by TME surgery with TME surgery alone. Patients who had an interval of more than 10 days between the start of radiotherapy and surgery were excluded from analysis. RESULTS: Differences were observed in tumor size (P < .001) and total number of examined lymph nodes (P < .001). No difference in tumor or node classification was detected. The irradiated group demonstrated more poorly differentiated tumors as well as more mucinous tumors. CONCLUSION: In rectal cancer patients, short-term, preoperative radiotherapy with 5 × 5 Gy does not lead to downstaging if the interval between the start of radiotherapy and surgery does not exceed 10 days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION
Quirke, P., Dixon, M. F., Durdey, P., & Williams, N. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92612-7 · Cited by 1,973
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma
Gastrointestinal Tumor Study Group (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122301 · Cited by 1,130
Role of circumferential margin involvement in the local recurrence of rectal cancer
Adam, I. J., Martin, I. G., Finan, P., Johnston, D., Mohamdee, M. O., Scott, N., Dixon, M. F., & Quirke, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92206-3 · Cited by 1,036
Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.21 · Cited by 1,030
Francois, Y., Nemoz, C. J., Baulieux, J., Vignal, J., Grandjean, J.-P., Partensky, C., Souquet, J. C., Adeleine, P., & Gerard, J.-P. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2396 · Cited by 815
A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCER
Jass, J. R., Love, S. B., & Northover, J. M. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90552-6 · Cited by 701
GÉRARD, A., BUYSE, M., NORDLINGER, B., LOYGUE, J., PÈNE, F., KEMPF, P., BOSSET, J.-F., GIGNOUX, M., ARNAUD, J.-P., DESAIVE, C., et al. (1988) · Annals of Surgery · doi:10.1097/00000658-198811000-00011 · Cited by 665
The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma
Cedermark, B., Johansson, H., Rutqvist, L. E., & The Stockholm Colorectal Cancer Study Group (1995) · Cancer · doi:10.1002/1097-0142(19950501)75:9<2269::aid-cncr2820750913>3.0.co;2-i · Cited by 639
Cited by
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
Self-citationWeitz, J., Koch, M., Debus, J., Höhler, T., Galle, P. R., & Büchler, M. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17706-x · Cited by 1,098
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?
Nagtegaal, I. D., & Quirke, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7027 · Cited by 1,006
Self-citationFolkesson, J., Birgisson, H., Pahlman, L., Cedermark, B., Glimelius, B., & Gunnarsson, U. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.144 · Cited by 868
Bosset, J.-F., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., Briffaux, A., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.113 · Cited by 594
Low Rectal Cancer: A Call for a Change of Approach in Abdominoperineal Resection
Nagtegaal, I. D., van de Velde, C. J. H., Marijnen, C. A. M., van Krieken, J. H. J. M., & Quirke, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9231 · Cited by 573
Self-citationBujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bębenek, M., Pudełko, M., Kryj, M., Olędzki, J., Szmeja, J., Słuszniak, J., et al. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2003.12.006 · Cited by 505
The Modern Abdominoperineal Excision: The Next Challenge After Total Mesorectal Excision
Marr, R., Birbeck, K., Garvican, J., Macklin, C. P., Tiffin, N. J., Parsons, W. J., Dixon, M. F., Mapstone, N. P., Sebag-Montefiore, D., Scott, N., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000167926.60908.15 · Cited by 436
An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients
Brouwer, N. P. M., Bos, A. C. R. K., Lemmens, V. E. P. P., Tanis, P. J., Hugen, N., Nagtegaal, I. D., de Wilt, J. H. W., & Verhoeven, R. H. A. (2018) · International Journal of Cancer · doi:10.1002/ijc.31785 · Cited by 304
Self-citationOn behalf of the Royal Marsden Hospital, C. C. N., Burton, S., Brown, G., Daniels, I. R., Norman, A. R., Mason, B., & Cunningham, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602947 · Cited by 291
S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008
Schmiegel, W., Reinacher-Schick, A., Arnold, D., Graeven, U., Heinemann, V, Porschen, R., Riemann, J., Rödel, C., Sauer, R., Wieser, M., et al. (2008) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027726 · Cited by 274
Moore, H. G., Gittleman, A. E., Minsky, B. D., Wong, D., Paty, P. B., Weiser, M., Temple, L., Saltz, L., Shia, J., & Guillem, J. G. (2004) · Diseases of the Colon & Rectum · doi:10.1007/s10350-003-0062-1 · Cited by 258
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer
Pettersson, D., Cedermark, B., Holm, T., Radu, C., Påhlman, L., Glimelius, B., & Martling, A. (2010) · British Journal of Surgery · doi:10.1002/bjs.6914 · Cited by 257
cT3N0 Rectal Cancer: Potential Overtreatment With Preoperative Chemoradiotherapy Is Warranted
Guillem, J. G., Díaz-González, J. A., Minsky, B. D., Valentini, V., Jeong, S.-Y., Rodriguez-Bigas, M. A., Coco, C., Leon, R., Hernandez-Lizoain, J. L., Aristu, J. J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5434 · Cited by 254
Metadata
- Authors
- Marijnen, C. A. M., Nagtegaal, I. D., Kranenbarg, E. K., Hermans, J., van de Velde, C. J. H., Leer, J. W. H., van Krieken, J. H. J. M., & for the Pathology Review Committee and the Cooperative Clinical Investigators
- Venue
- Journal of Clinical Oncology
- Published
- 2001-04-01
- Volume
- 19
- Issue
- 7
- Pages
- 1976-1984
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105768073
- Cited by
- 328
- References
- 30
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.